Canada - Re-Export of Penicillins or Streptomycins in Dosage Forms
Since 2014, Canada Re-Export of Penicillins or Streptomycins in Dosage Forms was up 165.4% year on year. In 2019, the country was number 8 among other countries in Re-Export of Penicillins or Streptomycins in Dosage Forms with $454,407.09. Canada is overtaken by Kenya, which was number 7 at $610,638.88 and is followed by Cyprus with $401,376.21. Italy topped the ranking with $158,707,704.07 in 2019, -22% versus 2018. United States, United Arab Emirates and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. Kenya witnessed the best average annual growth at +205.7% per year, while Trinidad and Tobago recorded the worst performance at -27.8% per year.
Loading...
Date | US Dollars |
---|---|
2019 | 454,407.09 |
2018 | 155,031.08 |
2017 | 13,518.46 |
2016 | 109,766.91 |
2015 | 8,649.28 |
Download all data from 2000 to 2019
How does Canada rank in Re-Export of Penicillins or Streptomycins in Dosage Forms?
# | 27 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Italy
|
158,707,704.07 | 2019 | -22.0 % | +57.7 % | View data | |
2 |
#2
United States
|
21,398,977.04 | 2019 | +3.5 % | +117.4 % | View data | |
7 |
#7
Kenya
|
610,638.88 | 2018 | +28.3 % | +205.7 % | View data | |
8 |
#8
Canada
|
454,407.09 | 2019 | +193.1 % | +165.4 % | View data | |
9 |
#9
Cyprus
|
401,376.21 | 2019 | +42.1 % | +16.1 % | View data |